Table of Contents
Influenza Research and Treatment
Volume 2011, Article ID 419216, 6 pages
http://dx.doi.org/10.1155/2011/419216
Review Article

Influenza Vaccination in the Face of Immune Exhaustion: Is Herd Immunity Effective for Protecting the Elderly?

1Department of Internal Medicine, Rehabilitation and Geriatrics, Medical school and University Hospitals of Geneva, CH-1226 Thônex-Geneva, Switzerland
2Translational Medicine Research Group, Cranfield Health, Cranfield University, Cranfield MK43 0AL, UK
3Nutrition Unit, Medical school and University Hospitals of Geneva, CH-1205 Geneva, Switzerland

Received 13 November 2011; Accepted 22 December 2011

Academic Editor: Zichria Zakay-Rones

Copyright © 2011 Pierre Olivier Lang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. R. Moxon and C. A. Siegrist, “The next decade of vaccines: societal and scientific challenges,” The Lancet, vol. 378, no. 9788, pp. 348–359, 2011. View at Publisher · View at Google Scholar
  2. World Health Organization, “Influenza vaccines,” The Weekly Epidemiological Record, vol. 80, no. 33, pp. 279–287, 2005. View at Google Scholar
  3. K. A. Poehling, K. M. Edwards, G. A. Weinberg et al., “The underrecognized burden of influenza in young children,” The New England Journal of Medicine, vol. 355, no. 1, pp. 31–40, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. W. J. Paget, C. Balderston, I. Casas et al., “Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project,” European Journal of Pediatrics, vol. 169, no. 8, pp. 997–1008, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. S. Monto, F. Ansaldi, R. Aspinall et al., “Influenza control in the 21st century: optimizing protection of older adults,” Vaccine, vol. 27, no. 37, pp. 5043–5053, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. E. McElhaney, “The unmet need in the elderly: designing new influenza vaccines for older adults,” Vaccine, vol. 23, supplement 1, pp. S10–S25, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. G. Gavazzi and K. H. Krause, “Ageing and infection,” Lancet Infectious Diseases, vol. 2, no. 11, pp. 659–666, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. P. O. Lang, S. Govind, W. A. Mitchell et al., “Influenza vaccine effectiveness in aged individuals: the role played by cell-mediated immunity,” European Geriatric Medicine, vol. 1, no. 4, pp. 233–238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. O. Lang, S. Govind, W. A. Mitchell, C. A. Siegrist, and R. Aspinall, “Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience,” Ageing Research Reviews, vol. 10, no. 3, pp. 389–395, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. N. A. Molinari, I. R. Ortega-Sanchez, M. L. Messonnier et al., “The annual impact of seasonal influenza in the US: measuring disease burden and costs,” Vaccine, vol. 25, no. 27, pp. 5086–5096, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. A. Siegrist and R. Aspinall, “B-cell responses to vaccination at the extremes of age,” Nature Reviews Immunology, vol. 9, no. 3, pp. 185–194, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. D. Weiskopf, B. Weinberger, and B. Grubeck-Loebenstein, “The aging of the immune system,” Transplant International, vol. 22, no. 11, pp. 1041–1050, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. R. Aspinall, D. Pitts, A. Lapenna, and W. Mitchell, “Immunity in the elderly: the role of the thymus,” Journal of Comparative Pathology, vol. 142, supplement 1, pp. S111–S115, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. Centers for Disease Control and Prevention, “Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP),” Morbidity and Mortality Weekly Report, vol. 53, no. 6, pp. 1–40, 2004. View at Google Scholar · View at Scopus
  15. K. Goodwin, C. Viboud, and L. Simonsen, “Antibody response to influenza vaccination in the elderly: a quantitative review,” Vaccine, vol. 24, no. 8, pp. 1159–1169, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. Simonsen, R. J. Taylor, C. Viboud, M. A. Miller, and L. A. Jackson, “Mortality benefits of influenza vaccination in elderly people: an ongoing controversy,” Lancet Infectious Diseases, vol. 7, no. 10, pp. 658–666, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. C. Nelson, M. L. Jackson, N. S. Weiss, and L. A. Jackson, “New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors,” Journal of Clinical Epidemiology, vol. 62, no. 7, pp. 687–694, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. T. M. Govaert, C. T. Thijs, N. Masurel, M. J. Sprenger, G. J. Dinant, and J. A. Knottnerus, “The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial,” Journal of the American Medical Association, vol. 272, no. 21, pp. 1661–1665, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Parodi, D. De Florentiis, M. Martini, and F. Ansaldi, “Inactivated influenza vaccines: recent progress and implication for the elderly,” Drugs & Aging, vol. 28, no. 2, pp. 93–106, 2011. View at Publisher · View at Google Scholar · View at PubMed
  20. T. Vesikari, M. Knuf, P. Wutzler et al., “Oil-in-water emulsion adjuvant with influenza vaccine in young children,” The New England Journal of Medicine, vol. 365, no. 15, pp. 1406–1416, 2011. View at Google Scholar
  21. T. Jefferson, A. Rivetti, A. Harnden, C. Di Pietrantonj, and V. Demicheli, “Vaccines for preventing influenza in healthy children,” Cochrane Database of Systematic Reviews, vol. 16, no. 2, article CD004879, 2008. View at Google Scholar · View at Scopus
  22. J. Rhorer, C. S. Ambrose, S. Dickinson et al., “Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials,” Vaccine, vol. 27, no. 7, pp. 1101–1110, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. R. B. Belshe, K. M. Edwards, T. Vesikari et al., “Live attenuated versus inactivated influenza vaccine in infants and young children,” The New England Journal of Medicine, vol. 356, no. 7, pp. 685–696, 2007. View at Google Scholar
  24. T. Vesikari, N. Groth, A. Karvonen, A. Borkowski, and M. Pellegrini, “MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination,” Vaccine, vol. 27, no. 45, pp. 6291–6295, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. T. Vesikari, M. Pellegrini, A. Karvonen et al., “Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant,” Pediatric Infectious Disease Journal, vol. 28, no. 7, pp. 563–571, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. D. Frasca, A. Diaz, M. Romero, A. M. Landin, and B. B. Blomberg, “Age effects on B cells and humoral immunity in humans,” Ageing Research Reviews, vol. 10, no. 3, pp. 330–335, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Govind, A. Lapenna, P. O. Lang, and R. Aspinall, “Immunotherapy of immunosenescence: who, how and when?” Open Longevity Science. In press.
  28. P. O. Lang, S. Govind, J. P. Michel, R. Aspinall, and W. A. Mitchell, “Immunosenescence: implications for vaccination programmes in adults,” Maturitas, vol. 68, no. 4, pp. 322–330, 2011. View at Publisher · View at Google Scholar · View at PubMed
  29. J. E. McElhaney, “Influenza vaccine responses in older adults,” Ageing Research Reviews, vol. 10, no. 3, pp. 379–388, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. R. B. Effros, “Role of T lymphocyte replicative senescence in vaccine efficacy,” Vaccine, vol. 25, no. 4, pp. 599–604, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. I. A. de Bruijn, J. Nauta, L. Gerez, and A. M. Palache, “The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad) in elderly subjects,” Vaccine, vol. 24, no. 44–46, pp. 6629–6631, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. I. de Bruijn, I. Meyer, L. Gerez, J. Nauta, K. Giezeman, and B. Palache, “Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly,” Vaccine, vol. 26, no. 1, pp. 119–127, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. P. O. Lang and R. Aspinall, “Immunosenescence and herd immunity: with an ever increasing aging population do we need to rethink vaccine schedules?” Expert Review of Vaccines, vol. 11, pp. 167–176, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. R. B. Effros, M. Dagarag, C. Spaulding, and J. Man, “The role of CD8+ T-cell replicative senescence in human aging,” Immunological Reviews, vol. 205, pp. 147–157, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. Centers for Disease Control and Prevention, “Impact of vaccines universally recommended for children—United States, 1990–1998,” Morbidity and Mortality Weekly Report, vol. 48, no. 12, pp. 243–248, 1999. View at Google Scholar
  36. J. P. Michel, P. O. Lang, and J. P. Baeyens, “Flu vaccination policy in old adults: need for harmonization of national public health recommendations throughout Europe,” Vaccine, vol. 27, no. 2, pp. 182–183, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. J. P. Michel, M. Gusmano, P. R. Blank, and I. Philp, “Vaccination and healthy ageing: how to make life-course vaccination a successful public health strategy,” European Geriatric Medicine, vol. 1, no. 3, pp. 155–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. P. Baeyens, P. O. Lang, and J. P. Michel, “Willingness to vaccinate and to be vaccinated in adults,” Aging, vol. 21, no. 3, pp. 244–249, 2009. View at Google Scholar · View at Scopus
  39. G. A. Poland, R. M. Jacobson, and I. G. Ovsyannikova, “Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics,” Vaccine, vol. 27, no. 25-26, pp. 3240–3244, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. G. A. Poland and R. M. Jacobson, “The age-old struggle against the antivaccinationists,” The New England Journal of Medicine, vol. 364, no. 2, pp. 97–99, 2011. View at Google Scholar
  41. A. E. Fiore, D. K. Shay, K. Broder et al., “Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008,” Morbidity and Mortality Weekly Report, vol. 57, no. 7, pp. 1–60, 2008. View at Google Scholar · View at Scopus
  42. T. Heikkinen, R. Booy, M. Campins et al., “Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts,” European Journal of Pediatrics, vol. 165, no. 4, pp. 223–228, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. J. P. Michel and P. O. Lang, “promoting life course vaccination,” Rejuvenation Research, vol. 14, no. 1, pp. 75–81, 2011. View at Publisher · View at Google Scholar · View at PubMed
  44. T. A. Reichert, N. Sugaya, D. S. Fedson, W. P. Glezen, L. Simonsen, and M. Tashiro, “The japanese experience with vaccinating schoolchildren against influenza,” The New England Journal of Medicine, vol. 344, no. 12, pp. 889–896, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. R. M. Anderson and R. M. May, “Immunisation and herd immunity,” The Lancet, vol. 335, no. 8690, pp. 641–645, 1990. View at Publisher · View at Google Scholar · View at Scopus
  46. T. J. John and R. Samuel, “Herd immunity and herd effect: new insights and definitions,” European Journal of Epidemiology, vol. 16, no. 7, pp. 601–606, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. Centers for Disease Control and Prevention, “Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008,” Morbidity and Mortality Weekly Report, vol. 57, no. 7, pp. 1–60, 2008. View at Google Scholar · View at Scopus
  48. W. R. Dowdle, J. D. Millar, L. B. Schonberger, F. A. Ennis, and J. R. LaMontagne, “Influenza immunization policies and practices in Japan,” Journal of Infectious Diseases, vol. 141, no. 2, pp. 258–264, 1980. View at Google Scholar
  49. Y. Hirota, D. S. Fedson, and M. Kaji, “Japan lagging in influenza jabs,” Nature, vol. 380, no. 6569, p. 18, 1996. View at Google Scholar · View at Scopus
  50. N. Sugaya and Y. Takeuchi, “Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan,” Clinical Infectious Diseases, vol. 41, no. 7, pp. 939–947, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. M. Takahashi and M. Nagai, “Estimation of excess mortality associated with influenza epidemics specific for sex, age and cause of death in Japan during 1987–2005,” Nippon Eiseigaku Zasshi, vol. 63, no. 1, pp. 5–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Cliff and P. Haggett, “Time, travel and infection,” British Medical Bulletin, vol. 69, pp. 87–99, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. G. A. Poland, I. G. Ovsyannikova, and R. M. Jacobson, “Application of pharmacogenomics to vaccines,” Pharmacogenomics, vol. 10, no. 5, pp. 837–852, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. A. Sette and R. Rappuoli, “Reverse vaccinology: developing vaccines in the era of genomics,” Immunity, vol. 33, no. 4, pp. 530–541, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. United Nations (UN), “World Population Ageing: 1950–2050,” November 2011, http://www.un.org/esa/population/publications/worldageing19502050/. View at Google Scholar
  56. J. Oeppen and J. W. Vaupel, “Demography. Broken limits to life expectancy,” Science, vol. 296, no. 5570, pp. 1029–1031, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. T. Fulop, A. Larbi, J. M. Witkowski et al., “Aging, frailty and age-related diseases,” Biogerontology, vol. 11, no. 5, pp. 547–563, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. P. O. Lang, W. A. Mitchell, A. Lapenna, D. Pitts, and R. Aspinall, “Immunological pathogenesis of main age-related diseases and frailty: role of immunosenescence,” European Geriatric Medicine, vol. 1, no. 2, pp. 112–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Franceschi, M. Capri, D. Monti et al., “Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans,” Mechanisms of Ageing and Development, vol. 128, no. 1, pp. 92–105, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. P. O. Lang, “Adverse effects of the herd immunity or when childhood vaccination becomes deleterious for the epidemiology of infectious diseases in adults,” Geriatr Psychol Neuropsychiatr Vieil, vol. 9, no. 1, pp. 11–19, 2011. View at Google Scholar
  61. P. R. Blank, M. Schwenkglenks, and T. D. Szucs, “Vaccination coverage rates in eleven European countries during two consecutive influenza seasons,” Journal of Infectious Diseases, vol. 58, no. 6, pp. 446–458, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. B. Michiels, F. Govearts, R. Remmen, E. Vermeire, and S. Coenen, “A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups,” Vaccine, vol. 29, no. 49, pp. 9159–9170, 2011. View at Publisher · View at Google Scholar · View at PubMed
  63. A. Nicoll and S. Tsolova, “Guidance priority risk groups for influenza vaccination. Stockholm: ECDC;,” 2008, http://ecdc.europa.eu/en/publications/Publications/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf. View at Google Scholar
  64. A. E. Fiore, T. M. Uyeki, K. Broder et al., “Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010,” Morbidity and Mortality Weekly Report, vol. 59, no. 8, pp. 1–62, 2010. View at Google Scholar · View at Scopus
  65. T. Jefferson, C. Di Pietrantonj, A. Rivetti, G. A. Bawazeer, L. A. Al-Ansary, and E. Ferroni, “Vaccines for preventing influenza in healthy adults,” Cochrane Database of Systematic Reviews (Online), vol. 7, article CD001269, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. R. E. Thomas, T. Jefferson, and T. J. Lasserson, “Influenza vaccination for healthcare workers who work with the elderly,” Cochrane Database of Systematic Reviews (Online), vol. 2, article CD005187, 2010. View at Google Scholar · View at Scopus
  67. R. E. Thomas, T. Jefferson, and T. J. Lasserson, “Influenza vaccination for healthcare workers who work with the elderly: systematic review,” Vaccine, vol. 29, no. 2, pp. 344–356, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus